Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concor AM Efficacy in Essential Hypertension
NCT01977794Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bisoprolol, amlodipine in essential hypertension, sponsored by Merck KGaA. Started Mar 2014; status: completed.
02
Drugs
bisoprololamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01977794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977794.